LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers

December 26, 2008 (PRLEAP.COM) Health News
Denver, CO — LegalView.com recently used its Baxter heparin information portal to report on additional controversy plaguing patients of the blood thinner. According to news reports, Rep. Joe Barton of Texas has claimed that the U.S. Food and Drug Administration (FDA) has given conflicting reports on the blood thinner, which is often given to prevent blood clots during surgical procedures including heart failure and kidney transplants, saying the drug was both responsible and not responsible for deaths of Americans. Rep. Barton has called for a Government Accountability Office (GAO) investigation into the FDA's remarks on the blood thinner.

A New England Journal of Medicine article from Dec. 3 claimed that the blood thinner could not have caused the deaths of several individuals, however this contradicted the FDA's previous remarks in May, which claimed that the drug was responsible for the deaths of patients, according to Dow Jones news reports.

Patients who have previously been administered the blood thinner are advised to locate an experienced Baxter heparin attorney who can offer a free legal consultation as to the development of a potential heparin class action lawsuit. Developing such litigation may offer monetary assistance to victims of the Heparin side effects and may help in paying for medical bills associated with the drug.

LegalView also offers several additional pharmaceutical practice areas on an array of topics ranging from Avandia and Byetta to the recent Chantix controversy. Both Avandia and Byetta are type 2 diabetes prescription medications, however, each drug has been in the news for different, yet severe side effects.

Avandia, from GlaxoSmithKline, uses an individual's natural insulin and regulates it in order to keep glucose on a normal and healthy level. Individuals who have suffered from the Avandia side effects are advised to contact a pharmaceutical attorney in addition to their regular medical physician.

Byetta, similar to Avandia, is a type 2 diabetes prescription medication that was released in mid-2005. In 2007, the FDA began receiving reports from Byetta patients who were suffering from pancreatitis as an unintended side effect associated with consumption of the drug. Patients who suffered from these dangers should seek legal counsel from an experienced Byetta law firm to learn more about the dangers associated with consumption of the medication.

An additional pharmaceutical prescription drug, which has sparked FDA investigations is that of Chantix, a smoking cessation drug that has been used by nearly 3 million Americans since its release in May 2006. Chantix patients were allegedly developing conditions such as depression, mood disorders as well as suicidal tendencies and actions. Additionally, it may be necessary for those individuals affected by the Chantix dangers to locate a pharmaceutical attorney for the potential development of a Chantix lawsuit.

About LegalView

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.